Skip to main content

Table 2 Adverse effects during Ramadan

From: Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational study

Adverse Effects

Groups

p-value

Total

Metformin + Sitagliptin

Metformin + Empagliflozin

n

%

n

%

n

%

Diarrhea

10

7.5

08

9.1

02

4.5

0.35

Rash

05

3.7

05

5.7

0

0

0.10

Hyperglycemia

09

6.8

06

6.8

03

6.8

1.0

Hypoglycemia

21

15.9

14

15.9

07

15.9

1.0

Urinary tract infection

10

7.5

06

6.8

00

0

0.077

Increased urination

23

17.4

13

14.8

10

22.7

0.25

Abdominal Pain

12

9.0

07

8

05

11.4

0.52

  1. p < 0.05 was considered significant using Independent Sample T Test